References

No references inside the corpus for this window.

Cited by

• 1990Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder96 cited
• 1997A Monoamine Hypothesis for the Pathophysiology of Paraphilic Disorders83 cited
• 2018Antidepressants versus placebo for panic disorder in adults76 cited
• 2002Acute l-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients65 cited
• 1988Monoamine Receptor Systems and Anxiety Disorders63 cited
• 1992The galway study of panic disorder I:58 cited
• 1989Serotonin function in panic disorder: effect of 1–5-hydroxytryptophan in patients and controls57 cited
• 1987Antidepressant drugs in anxiety disorders50 cited
• 1987Aetiology and mechanisms of anxiety disorders48 cited
• 1996Developments in the drug treatment of panic disorder: What is the place of the selective serotonin reuptake inhibitors?46 cited
• 1993Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine44 cited
• 1991Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects43 cited
• 1989Antidepressants in Panic Disorders41 cited
• 1996Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder